Huang Shujun, Kurubanjerdjit Nilubon, Xu Wayne
College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Research Institute of Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, Manitoba, Canada.
Research Institute of Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, Manitoba, Canada.
Crit Rev Oncog. 2017;22(1-2):143-155. doi: 10.1615/CritRevOncog.2017020882.
In this review, we introduce a new vision of cancer describing opposing effects that control progression. Cancer is a paradigm of opposing of "Yin" and "Yang," with Yin being the effect to promote cancer and Yang that to maintain the normal state. This Yin Yang hypothesis has been used to select Yin and Yang genes to develop multigene signatures for determining prognosis in lung and breast cancer. Most of the Yin genes are involved in cell survival, growth, and proliferation, whereas most Yang genes are involved in cell apoptosis. Furthermore, Yin and Yang pathways have been identified in breast cancer and compounds that can inhibit the Yin pathways or activate the Yang pathways have been examined, suggesting a new promising targeting therapy for cancer. We are building a Yin Yang model to represent the dynamic change of Yin and Yang genes and pathways.
在本综述中,我们介绍了一种关于癌症的新观点,描述了控制癌症进展的相反作用。癌症是“阴”与“阳”对立的范例,阴是促进癌症的作用,阳是维持正常状态的作用。这种阴阳假说已被用于选择阴阳基因,以开发多基因特征来确定肺癌和乳腺癌的预后。大多数阴基因参与细胞存活、生长和增殖,而大多数阳基因参与细胞凋亡。此外,在乳腺癌中已鉴定出阴阳通路,并且对可抑制阴通路或激活阳通路的化合物进行了研究,这表明了一种新的有前景的癌症靶向治疗方法。我们正在构建一个阴阳模型来代表阴阳基因和通路的动态变化。